AMEDICA ANNOUNCES CORPORATE NAME CHANGE TO SINTX TECHNOLOGIES, INC.
October 31, 2018 09:00 ET
|
Amedica Corporation
SALT LAKE CITY, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, announced that it has...
AMEDICA ANNOUNCES CLOSING OF THE SALE OF ITS SPINE BUSINESS TO CTL MEDICAL
October 03, 2018 09:00 ET
|
Amedica Corporation
SALT LAKE CITY, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA) today announced that it has completed the previously-announced sale of its spine business to CTL Medical, a...
Amedica Corporation to Host Conference Call to Discuss Recent Sale of Spine Implant Business and Transition to Biomaterials Company
September 11, 2018 09:00 ET
|
Amedica Corporation
SALT LAKE CITY, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, announced today that...
AMEDICA ANNOUNCES FILING OF KEY PATENT APPLICATION RELATING TO THE ANTI-VIRAL EFFECT OF ITS SILICON NITRIDE
September 10, 2018 09:00 ET
|
Amedica Corporation
SALT LAKE CITY, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, today announced the...
AMEDICA ANNOUNCES AGREEMENT TO SELL SPINE BUSINESS TO CTL MEDICAL
September 06, 2018 09:00 ET
|
Amedica Corporation
SALT LAKE CITY, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA) today announced that it has entered into an asset purchase agreement with CTL Medical, a Dallas, TX-based...
Amedica Announces Successful Completion of First Valeo® C+CSC with Lumen Interbody Fusion Surgery
August 21, 2018 09:00 ET
|
Amedica Corporation
SALT LAKE CITY, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications,...
Amedica Corporation Announces Closing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and Warrants
May 14, 2018 16:26 ET
|
Amedica Corporation
SALT LAKE CITY, May 14, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA) an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications,...
Amedica Corporation Announces Pricing of $15,000,000 Public Offering of Units Consisting of Convertible Preferred Stock and Warrants
May 10, 2018 09:20 ET
|
Amedica Corporation
SALT LAKE CITY, May 10, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA) an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications,...
Amedica Corporation Provides Update on its Clinical Studies
May 08, 2018 09:30 ET
|
Amedica Corporation
SALT LAKE CITY, May 08, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications,...
Amedica Announces Patent Grant for Silicon Nitride and Other Ceramic Materials
March 30, 2018 09:00 ET
|
Amedica Corporation
SALT LAKE CITY, March 30, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical...